Aller au contenu principal
Fermer

Transgene Reports Results from Clinical Study of TG4001 in Combination with Avelumab in Advanced HPV-Positive Cancers
information fournie par Boursorama CP 22/07/2020 à 16:31
Ajouter Boursorama à vos sources

- Exploratory Phase 1b/2 trial targeting a heterogeneous population of patients with HPV16-positive, recurrent and/or metastatic cancer whose disease has progressed after up to three lines of chemotherapy, reports promising clinical activity with the combination regimen.

Valeurs associées

0,8540 EUR Euronext Paris -0,12%

0 commentaire

Signaler le commentaire

Fermer

A lire aussi

Mes listes

valeur

dernier

var.

99,85 -0,17%
0,637 +20,64%
8 154,91 +0,20%
29,36 +2,80%
152,05 -1,81%
Chargement...